Risk Assessments
Embedded Files
The Pathway
Every DTC assessment sits inside one connected pathway. The pathway, not any single test, is what helps turn a routine visit into earlier, provider-directed action.
Screen. Every visit begins with direction. TriageIQ™, our 3-minute patient-administered pre-screener, identifies chronic-risk signals across whole-person clinical domains at intake. The results are reviewed and scored within the clinical workflow, helping point the provider toward what may matter most for that patient.
Test. When the pre-screen surfaces a risk signal, the provider may select from DTC’s suite of validated, non-invasive assessments. Which assessment, if any, is appropriate remains the provider’s clinical determination. Findings are documented, not assumed.
Treat. The provider acts on what the assessment findings support, initiating appropriate follow-up, care planning, treatment, monitoring, or referral as clinically indicated. The goal is to support earlier action inside the existing workflow, before patients are missed or delayed.
The compass points; the provider drives. TriageIQ™ and DTC assessments help flag, document, and route risk signals toward provider-directed follow-up. The treating provider remains solely responsible for diagnosis, testing decisions, treatment, documentation, and all clinical determinations.
Screen. Test. Treat.
What's Available Through DTC
The following validated assessments, screening services, and monitoring technologies are available through DTC. Which service, if any, is clinically appropriate for a given patient remains the treating provider’s determination.
Neurological & Sensory
AI Diabetic Retinopathy
Cognitive Testing
Diabetic Neuropathy Device™
Electronic Tuning Fork
Hearing Loss
Cardiometabolic
A1c Fingerstick
Cardiac Monitoring
CardioANS
TruABI™
TruPAD
Behavioral
Behavioral Test
Diabetes Distress
Psych Screening
Functional & Balance
Balance & Gait
Fall-Risk Assessment
Sleep Studies & OSA (Therapy)
Patient Support
Patient Counseling & Education
Private Screening
The grouping above is designed to help patients and practices understand the available care pathways. It does not disclose which pre-screen signal routes to which assessment. That clinical-routing logic is proprietary and remains behind the wall.
Why the Pathway Matters, Not Just a Test
Why the Pathway Matters, Not Just a Test
A single test may answer one question. A connected pathway can change how a practice works.
Every visit has direction. Patients are not evaluated at random; the visit begins with structured risk signals.
Findings are documented. The provider has organized, patient-specific information to support their own determination of medical necessity and next steps.
Action can happen in-visit. Earlier insight helps providers act sooner, inside the existing workflow.
Outcomes compound. Screening informs testing, testing informs treatment, and treatment informs ongoing management.
DTC assessments help flag risk signals and route patients toward provider-directed follow-up. The treating provider remains solely responsible for diagnosis, testing decisions, treatment, documentation, and all clinical determinations. DTC assessments do not diagnose.
Early Detection Gives Patients More Time
Test Beyond Blood Sugars
Test Beyond Blood Sugars
Page updated
Report abuse